# A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

> **NCT06655870** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **ModernaTX, Inc.** · enrollment: 52 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** mRNA-0184

## Key facts

- **NCT ID:** NCT06655870
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2026-06-23
- **Final completion:** 2026-06-23
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655870, "A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06655870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*